Medicamen Biotech Ltd.
MEDICAMEQ Share PricePharmaceuticals & Drugs
₹389.05
2.1 (0.5%)
As on December 4, 2025
Exchange Scrips: BSE531146NSEMEDICAMEQISININE646B01010
Market Cap ₹ 528 Cr
P/E Ratio 75.46
Dividend Yield 0.03 %
Performance
Market performance
Open380
High391.1
Volumes8,030
Prev389.05
Low380
As on2025-12-04
Historical performance
1 Year High630
3 Year High902.5
5 Year High1,225
1 Year Low292.95
3 Year Low292.95
5 Year Low292.95
Fundamentals
Company Valuation
Market Cap (₹Cr)
528
Face Value (₹)
10
P/E Ratio
75.46
Dividend Yield
0.03 %
Investment Returns
1 Year
-26.4%
3 Years
-53.8%
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 395.76 | Bearish |
| 10-DMA | 402.42 | Bearish |
| 20-DMA | 403.31 | Bearish |
| 50-DMA | 359.69 | Bullish |
| 100-DMA | 362.29 | Bullish |
| 200-DMA | 404.79 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 1 | 1 | 1 | 1 | 1 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 1 | 1 | 1 | 1 | 1 |
| Public Investors | 11176 | 10807 | 10434 | 10575 | 10791 |
| Government | 1 | 1 | 1 | 1 | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 75.46.
- 3Y Stock Price CAGR of the stock is -22.9.
- The stock has a beta of 1.2.
- In the last financial year, the company had an EBITDA of ₹207 Million.
- The company generated revenue of ₹1625 Million in the previous financial year.
Medicamen Biotech Ltd.
389.052.1 (0.5%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 671238.8
No. of Shares: 1725 (Approx)
Performance:-32.9%
P/L: ₹-328761.2
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
